Abstract
Allele imbalance on chromosome 11 loci in ovarian cancer is a frequent event, suggesting the presence of tumour-suppressor genes for ovarian carcinogenesis on this chromosome. Ten highly polymorphic (CA) repeat microsatellites were used to determine allele imbalance in 60 primary ovarian tumours, including 47 epithelial ovarian cancers (EOCs). Forty EOCs (85%) showed allele imbalance at one or more loci, and in 39 of these (83%) the data suggested subchromosomal deletions: eight of 11p only; six of 11q only; and 25 of both 11p and 11q. Three consensus regions of deletion were indicated at 11p15.5-p15.3, 11q12-q22 and 11q23.3-q24.1. Allele imbalance at the 11q subtelomeric region (D11S912) correlated significantly with adverse survival, while imbalance at 11q14.3 and retention of heterozygosity at 11q22 (close to the site of the progesterone receptor gene) were associated with favourable clinicopathological features. The findings allow development of a preliminary model for the molecular evolution of epithelial ovarian cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gabra, H., Taylor, L., Cohen, B. et al. Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours. Br J Cancer 72, 367–375 (1995). https://doi.org/10.1038/bjc.1995.340
Issue Date:
DOI: https://doi.org/10.1038/bjc.1995.340
This article is cited by
-
Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers
Cancer Gene Therapy (2021)
-
Physical activity, body size and composition, and risk of ovarian cancer
Cancer Causes & Control (2010)
-
Increasing expression of serine protease matriptase in ovarian tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters
Modern Pathology (2006)
-
Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling
Oncogene (2005)
-
Estrogen-induced loss of progesterone receptor expression in normal and malignant ovarian surface epithelial cells
Oncogene (2005)